Vaginitis: Diagnosis and Management

References

• . Anderson MB, Klink K, Cohrssen A. Evaluation of vaginal complaints. JAMA. 2004;291(11):1368–1379
   PubMed Web of Science ®Google Scholar
• . Eckert LO. Clinical practice: acute vulvovaginitis. N Engl J Med. 2006;355(12):1244–1252
   PubMed Web of Science ®Google Scholar
• . Brown HL, Fuller DD, Jasper LT, Davis TE, Wright JD. Clinical evaluation of affirm VPIII in the detection and identification of Trichomonas vaginalis, Gardnerella vaginalis, and Candida species in vaginitis/vaginosis. Infect Dis Obstet Gynecol. 2004;12(1):17–21
   PubMedGoogle Scholar
• . Landers DV, Wiesenfeld HC, Heine RP, Krohn MA, Hillier SL. Predictive value of the clinical diagnosis of lower genital tract infection in women. Am J Obstet Gynecol. 2004;190(4):1004–1010
   PubMed Web of Science ®Google Scholar
• . Ferris DG, Nyirjesy P, Sobel JD, Soper D, Pavletic A, Litaker MS. Over-the-counter antifungal drug misuse associated with patient-diagnosed vulvovaginal candidiasis. Obstet Gynecol. 2002;99(3):419–425
   PubMed Web of Science ®Google Scholar
• . Allen-Davis JT, Beck A, Parker R, Ellis JL, Polley D. Assessment of vulvovaginal complaints: accuracy of telephone triage and in-office diagnosis. Obstet Gynecol. 2002;99(1):18–22
   PubMed Web of Science ®Google Scholar
• . Cibley LJ, Cibley LJ. Cytolytic vaginosis. Am J Obstet Gynecol. 1991;165(4 pt 2):1245–1249
   PubMed Web of Science ®Google Scholar
• . Ledger WJ, Monif GR. A growing concern: inability to diagnose vulvovaginal infections correctly. Obstet Gynecol. 2004:103(4):782–784
   PubMed Web of Science ®Google Scholar
• . Fleury FJ. Adult vaginitis. Clin Obstet Gynecol. 1981:24(2):407–438
   PubMedGoogle Scholar
• . Nyirjesy P, Peyton C, Weitz MV, Mathew L, Culhane JF. Causes of chronic vaginitis. Obstet Gynecol. 2006;108(5):1185–1191
   PubMed Web of Science ®Google Scholar
• . Quan M. Diagnosis and management of infectious vaginitis. J Am Board Fam Pract. 1990:3(3):195–205
   PubMedGoogle Scholar
• . Fredricks DN, Fiedler TL, Marrazzo JM. Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med. 2005;353(18):1899–1911
   PubMed Web of Science ®Google Scholar
• . Swidsinski A, Mendling W, Loening-Baucke V, . An adherent Gardnerella vaginalis biofilm persists on the vaginal epithelium after standard therapy with oral metronidazole. Am J Obstet Gynecol. 2008;198(1):97.e1–e6
   Web of Science ®Google Scholar
• . Menard JP, Mazouni C, Salem-Cherif I, . High vaginal concentrations of Atopobium vaginae and Gardnerella vaginalis in women undergoing preterm labor. Obstet Gynecol. 2010;115(1):134–140
   PubMed Web of Science ®Google Scholar
• . Sobel JD. What's new in bacterial vaginosis and trichomoniasis. Infect Dis Clin North Am. 2005;19(2):387–406
   PubMed Web of Science ®Google Scholar
• . Brand JM, Galask P. Trimethylamine: the substance mainly responsible for the fishy odor often associated with bacterial vaginosis. Obstet Gynecol. 1986;68(5):682–685
   PubMed Web of Science ®Google Scholar
• . Koumans EH, Sternberg M, Bruce C, . The prevalence of bacterial vaginosis in the United States 2001-2004; associations with symptoms, sexual behaviors, and reproductive health. Sex Trans Dis. 2007;34(11):864–869
   PubMed Web of Science ®Google Scholar
• . Fethers KA, Fairley CK, Hocking JS, Gurrin LC, Bradshaw CS. Sexual risk factors and bacterial vaginosis: a systematic review and meta-analysis. Clin Infect Dis. 2008;47(11):1426–1435
   PubMed Web of Science ®Google Scholar
• . Klebanoff MA, Schwebke JR, Zhang J, . Vulvovaginal symptoms in women with bacterial vaginosis. Obstet Gynecol. 2004;104(2):267–272
   PubMed Web of Science ®Google Scholar
• . Leitich H, Kiss H. Asymptomatic bacterial vaginosis and intermediate flora as risk factors for adverse pregnancy outcomes. Clin Obstet Gynecol. 2007;21(3):375–390
   Google Scholar
• . Nygren P, Fu R, Freeman M, Bougatsos C, Klebanoff M, Guise JM; U.S. Preventive Services Task Force. Evidence on the benefits and harms of screening and treating pregnant women who are asymptomatic for bacterial vaginosis: an update review for the U.S. preventive services task force. Ann Intern Med. 2008;148(3):220–233
   PubMed Web of Science ®Google Scholar
• . Koumans EH, Markowitz LE, Hogan V; CDC BV Working Group. Indications for therapy and treatment recommendations for bacterial vaginosis in nonpregnant and pregnant women: a synthesis of data. Clin Infect Dis. 2002;35( suppl 2):S152–S172
   PubMed Web of Science ®Google Scholar
• . Nyirjesy P. Vulvovaginal candidiasis and bacterial vaginosis. Infect Dis Clin N Am. 2008;22(4):637–652
   PubMed Web of Science ®Google Scholar
• . Atashili J, Poole C, Ndumbe PM, Adimora AA, Smith JS. Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. AIDS. 2008;22(12):1493–1501
   PubMed Web of Science ®Google Scholar
• . Richter SS, Galask RP, Messer SA, Hollis RJ, Diekema DJ, Pfaller MA. Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases. J Clin Microbiol. 2005;43(5):2155–2162
   PubMed Web of Science ®Google Scholar
• . Sobel JD. Vulvovaginal candidosis. Lancet. 2007;369(9577):1961–1971
   PubMed Web of Science ®Google Scholar
• . ; Centers for Disease Control and PreventionWorkowski KA, Berman SM. Sexually transmitted disease treatment guidelines 2006. Centers for Disease Control and Prevention. MMWR Recomm Rep. 2006:55(RR-11):1–94
   Google Scholar
• . Whittington MJ. Epidemiology of infections with Trichomonas vaginalis in the light of improved diagnostic methods. Br J Vener Dis. 1957:33(2):80–91
   PubMedGoogle Scholar
• . ACOG Committee on Practice Bulletins–Gynecology. ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists, Number 72, May 2006: Vaginitis. Obstet Gynecol. 2006;107(5):1195–1206
   PubMedGoogle Scholar
• . Wendel KA, Workowski KA. Trichomoniasis: challenges to appropriate management. Clin Infect Dis. 2007;44( suppl 3):S123–S129
   PubMed Web of Science ®Google Scholar
• . Peterman TA, Tian LH, Metcalf CA, : Persistent, undetected Trichomonas vaginalis infections? Clin Infect Dis. 2009:48(2):259–260
   PubMed Web of Science ®Google Scholar
• . Soper D. Trichomoniasis: under control or undercontrolled. Am J Obstet Gynecol. 2004:190(1):281–290
   PubMed Web of Science ®Google Scholar
• . Spence DS, Melville C. Vaginal discharge. BMJ. 2007;335(7630):1147–1151
   PubMed Web of Science ®Google Scholar
• . French L, Horton J, Matousek M. Abnormal vaginal discharge: using office diagnostic testing more effectively. J Fam Pract. 2004;53(11):805–814
   PubMed Web of Science ®Google Scholar
• . Miller WC, Zenilman JM. Epidemiology of chlamydial infection gonorrhea, and trichomoniasis in the United States–2005. Infect Dis Clin North Am. 2005;19(2):281–296
   PubMed Web of Science ®Google Scholar
• . Marrazzo JM, Martin DH. Management of women with cervicitis. Clin Infect Dis. 2007;44( suppl 3):S102–S110
   Web of Science ®Google Scholar
• . Marrazzo JM, Handsfield HH, Whittington WL. Predicting chlamydial and gonococcal cervical infection: implications for management of cervicitis. Obstet Gynecol. 2002:100(3):579–584
   PubMed Web of Science ®Google Scholar
• . Sharp HC. Vulvovaginal conditions mimicking vaginitis. Clin Obstet Gynecol. 1993;36(1):129–136
   PubMed Web of Science ®Google Scholar
• . Bachman GA, Nevadunsky NS. Diagnosis and treatment of atrophic vaginitis. Am Fam Physician. 2000;61(10):3090–3096
   PubMed Web of Science ®Google Scholar
• . North American Menopause Society. The role of local vaginal estrogen for treatment of vaginal atrophy: 2007 position statement of the North American Menopause Society. Menopause. 2007;14(3 pt 1):355–370
   PubMed Web of Science ®Google Scholar
• . Murphy R, Edwards L. Desquamative inflammatory vaginitis: what is it? J Reprod Med. 2008:53(2):124–128
   PubMed Web of Science ®Google Scholar
• . Sobel JD. Desquamative inflammatory vaginitis: a new subgroup of purulent vaginitis responsive to topical 2% clindamycin therapy. Am J Obstet Gynecol. 1994;171(5):1215–1220
   PubMed Web of Science ®Google Scholar
• . Horowitz BJ, Mardh P, Nagy E, Rank EL. Vaginal lactobacillosis. Am J Obstet Gynecol. 1994;170(3):857–861
   PubMed Web of Science ®Google Scholar
• . Donders GG, Vereecken A, Bosmans E, Dekeersmaecker A, Salembier G, Spitz B. Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis. BJOG. 2002;109(1):32–43
   Web of Science ®Google Scholar
• . Joesoef MR, Karundeng A, Runtupalit C, Moran JS, Lewis JS, Ryan CA. High rate of bacterial vaginosis in women with intrauterine devices in Manado, Indonesia. Contraception. 2001;64(3):169–172
   PubMed Web of Science ®Google Scholar
• . Meirik O. Intrauterine devices–upper and lower genital tract infections. Contraception. 2007;75( 6 suppl):S41–S47
   PubMed Web of Science ®Google Scholar
• . Geisler WM, Venglarik M, Schwebke JR. Vaginal leucocyte counts in women with bacterial vaginosis: relation to vaginal and cervical infections. Sex Trans Infect. 2004;80(5):401–405
   PubMed Web of Science ®Google Scholar
• . Amsel R, Totten PA, Spiegel CA, Chen KC, Eschenbach D, Holmes KK. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med. 1983;74(1):14–22
   PubMed Web of Science ®Google Scholar
• . Sobel JD, Vazquez J, Lynch M, . Vaginitis due to Saccharomyces cerevisiae: epidemiology, clinical aspects, and therapy. Clin Infect Dis. 1993;16(1):93–99
   PubMed Web of Science ®Google Scholar
• . Thinkhamrop J, Lumbiganon P, Thongkrajel P, Chongsomchai C, Pakarasang M. Vaginal fluid pH as a screening test for vaginitis. Int J Gynecol Obstet. 1999;66(2):143–148
   PubMed Web of Science ®Google Scholar
• . West B, Morison L, Van der Loeff MS, . Evaluation of a new rapid diagnostic kit (FemExam) for bacterial vaginosis in patients with vaginal discharge syndrome in the Gambia. STD. 2003;30(6):483–489
   PubMed Web of Science ®Google Scholar
• . Lowe NK, Neal JL, Ryan-Wenger NA. Accuracy of the clinical diagnosis of vaginitis compared with a DNA probe laboratory standard. Obstet Gynecol. 2009;113(1):89–95
   PubMed Web of Science ®Google Scholar
• . Huppert JS, Batteiger BE, Braslins P, . Use of an immunochro-matographic assay for rapid detection of trichomonas vaginalis in vaginal specimens. J Clin Microbiol. 2005;43(2):684–687
   PubMed Web of Science ®Google Scholar
• . Sobel JD, Kapernick PS, Zervos M, : Treatment of complicated Candida vaginitis: comparison of single and sequential doses of fluconazole. Am J Obstet Gynecol. 2001;185(2):363–369
   PubMed Web of Science ®Google Scholar
• . Sobel JD, Chaim W, Nagappan V, . Treatment of vaginitis caused by Candida glabrata: use of topical boric acid and flucytosine. Am J Obstet Gynecol. 2003;189(5):1297–1300
   PubMed Web of Science ®Google Scholar
• . Horowitz BJ. Topical flucytosine therapy for chronic recurrent Candida tropicalis infections. J Reprod Med. 1986;31(9):821–824
   PubMed Web of Science ®Google Scholar
• . Sobel JD. Recurrent vulvovaginal candidiasis. N Engl J Med. 1986;315(23):1455–1458
   PubMed Web of Science ®Google Scholar
• . Sobel JD, Wiesenfeld HC, Martens M, . Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis. N Engl J Med. 2004;351(9):876–883
   PubMed Web of Science ®Google Scholar
• . Fung HB, Doan T. Tinidazole: a nitroimidazole antiprotozoal drug. Clin Ther. 2005;27(12):1859–1884
   PubMed Web of Science ®Google Scholar
• . Okun N, Gronau KA, Hannah ME. Antibiotics for bacterial vaginosis or trichomonas vaginalis in pregnancy: a systematic review. Obstet Gynecol. 2005:105(4):857–868
   PubMed Web of Science ®Google Scholar
• . Nyirjesy P, Sobel JD, Weitz MV, Leaman DJ, Gelone SP. Difficult-to-treat trichomoniasis: results with paromomycin cream. Clin Infect Dis. 1998;26(4):986–988
   PubMed Web of Science ®Google Scholar
• . Poppe WA. Nitroimidazole-resistant vaginal trichomoniasis treated with paromomycin. Eur J Obstet Gynecol Reprod Biol. 2001;96(1):119–120
   PubMed Web of Science ®Google Scholar
• . Tayal SC, Ochogwu SA, Bunce H. Paromomycin treatment of recalcitrant Trichomonas vaginalis. Int J STD AIDS. 2010;21(3):217–218
   PubMed Web of Science ®Google Scholar
• . Gutman RE, Peipert JF, Weitzen S, Blume J. Evaluation of clinical methods for diagnosing bacterial vaginosis. Obstet Gynecol. 2005;105(3):551–556
   PubMed Web of Science ®Google Scholar
• . Nugent RP, Krohn MA, Hillier S. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol. 1991:29(2):297–301
   PubMed Web of Science ®Google Scholar
• . Pheifer TA, Forsyth PS, Durfee MA, Pollock HM, Holmes KK. Nonspecific vaginitis: role of Haemophilus vaginalis and treatment with metronidazole. N Engl J Med. 1978;298(26):1429–1434
   PubMed Web of Science ®Google Scholar
• . Livengood CH, Ferris DG, Wiesenfeld HC, . Effectiveness of two tinidazole regimens in treatment of bacterial vaginosis: a randomized controlled trial. Obstet Gynecol. 2007:110(2 pt 1):302–309
   PubMed Web of Science ®Google Scholar
• . Bunge KE, Beigi RH, Meyn LA, Hillier SL. The efficacy of retreatment with the same medication for early treatment failure of bacterial vaginosis. Sex Trans Dis. 2009;36(11):711–713
   PubMed Web of Science ®Google Scholar
• . Sobel JD, Ferris D, Schwebke J, . Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis. Am J Obstet Gynecol. 2006;194:1283–1289
   PubMed Web of Science ®Google Scholar
• . Reichman O, Akins R, Sobel JD. Boric acid addition to suppressive antimicrobial therapy for recurrent bacterial vaginosis. Sex Trans Dis. 2009;36(11):732–734
   PubMed Web of Science ®Google Scholar
• . Schwebke JR, Desmond R. A randomized trial of metronidazole in asymptomatic bacterial vaginosis to prevent the acquisition of sexually transmitted diseases. Am J Obstet Gynecol. 2007;196(6):517.e1–e6
   PubMed Web of Science ®Google Scholar
• . Ness RB, Kip KE, Soper DE. Variability of bacterial vaginosis over 6- to 12-month intervals. Sex Trans Dis. 2006;33(6):381–385
   PubMed Web of Science ®Google Scholar
• . Klebanoff MA, Hauth JC, MacPherson CA, ; National Institute for Child Health and Development Maternal Fetal Medicine Units Network. Time course of the regression of asymptomatic bacterial vaginosis in pregnancy with and without treatment. Am J Obstet Gynecol. 2004;190(2):363–370
   PubMed Web of Science ®Google Scholar
• . Carey JC, Klebanoff MA, Hauth JC, . Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. N Engl J Med. 2000:342(8):534–540
   PubMed Web of Science ®Google Scholar
• . U.S. Preventive Services Task Force. Screening for bacterial vaginosis in pregnancy to prevent preterm delivery: U.S. preventive services task force recommendation statement. Ann Intern Med. 2008:148(12):214–219
   PubMed Web of Science ®Google Scholar